Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-01-18 4:29 pm Purchase | 2023-12-31 | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% | 3,545,496![]() (+70.81%) | Filing History |
2024-01-18 4:18 pm Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | BIOTECHNOLOGY VALUE FUND L P | 8,902,972 9.900% | 8,902,972![]() (New Position) | Filing History |
2024-01-16 5:22 pm Purchase | 2024-01-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% | 103,200![]() (+2.92%) | Filing History |
2024-01-09 4:45 pm Purchase | 2024-01-05 | 13D | Kymera Therapeutics, Inc. KYMR | BIOTECHNOLOGY VALUE FUND L P | 5,831,171 9.990% | 1,138,567![]() (+24.26%) | Filing History |
2023-12-20 4:38 pm Sale | 2023-12-18 | 13D | POINT Biopharma Global Inc. PNT | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -17,437,375![]() (Position Closed) | Filing History |
2023-12-20 4:36 pm Sale | 2023-12-18 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.800% | -10,221,554![]() (-80.74%) | Filing History |
2023-12-19 4:53 pm Purchase | 2023-12-15 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.800% | 7,142,857![]() (+96.16%) | Filing History |
2023-12-18 4:35 pm Unchanged | 2023-12-13 | 13D | Rain Enhancement Technologies Holdco Inc RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% | 0 (Unchanged) | Filing History |
2023-12-04 4:33 pm Purchase | 2023-11-22 | 13G | SAB Biotherapeutics, Inc. SABS | BIOTECHNOLOGY VALUE FUND L P | 917,828 9.990% | 917,828![]() (New Position) | Filing History |
2023-11-20 5:07 pm Purchase | 2023-11-17 | 13D | Molecular Partners AG MOLN | BIOTECHNOLOGY VALUE FUND L P | 8,696,205 23.900% | 2,203,688![]() (+33.94%) | Filing History |
2023-11-17 4:52 pm Purchase | 2023-11-15 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.500% | 1,235,000![]() (+13.57%) | Filing History |
2023-11-13 4:45 pm Purchase | 2023-10-31 | 13G | enGene Holdings Inc. Common Stock ENGN | BIOTECHNOLOGY VALUE FUND L P | 3,196,439 13.200% | 3,196,439![]() (New Position) | Filing History |
2023-11-07 4:41 pm Purchase | 2023-11-03 | 13G | Molecular Partners AG MOLN | BIOTECHNOLOGY VALUE FUND L P | 6,492,517 17.900% | 1,982,445![]() (+43.96%) | Filing History |
2023-11-06 1:47 pm Purchase | 2023-11-02 | 13D | POINT Biopharma Global Inc. PNT | BIOTECHNOLOGY VALUE FUND L P | 17,437,375 16.500% | 8,259,627![]() (+90.00%) | Filing History |
2023-11-03 5:20 pm Purchase | 2023-11-02 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.600% | 806,612![]() (+9.73%) | Filing History |
2023-10-16 4:34 pm Purchase | 2023-10-04 | 13G | VistaGen Therapeutics, Inc. VTGN | BIOTECHNOLOGY VALUE FUND L P | 2,777,245 9.990% | 2,777,245![]() (New Position) | Filing History |
2023-09-25 4:35 pm Purchase | 2023-08-31 | 13D | Inventiva S.A. IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 16.500% | 587,361![]() (+7.38%) | Filing History |
2023-09-18 4:35 pm Purchase | 2023-09-07 | 13G | Mirum Pharmaceuticals, Inc. MIRM | BIOTECHNOLOGY VALUE FUND L P | 4,370,024 9.400% | 4,370,024![]() (New Position) | Filing History |
2023-09-14 4:23 pm Purchase | 2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA | BIOTECHNOLOGY VALUE FUND L P | 9,135,893 16.700% | 1,724,390![]() (+23.27%) | Filing History |
2023-08-17 4:52 pm Unchanged | 2023-08-10 | 13D | Rain Enhancement Technologies Holdco Inc RAIN | BIOTECHNOLOGY VALUE FUND L P | 3,526,729 12.800% | 0 (Unchanged) | Filing History |